PT3468974T - Novos derivados de piperidinilo, um processo para a sua preparação e composições farmacêuticas que os contêm - Google Patents

Novos derivados de piperidinilo, um processo para a sua preparação e composições farmacêuticas que os contêm

Info

Publication number
PT3468974T
PT3468974T PT177279270T PT17727927T PT3468974T PT 3468974 T PT3468974 T PT 3468974T PT 177279270 T PT177279270 T PT 177279270T PT 17727927 T PT17727927 T PT 17727927T PT 3468974 T PT3468974 T PT 3468974T
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
piperidinyl derivatives
new piperidinyl
Prior art date
Application number
PT177279270T
Other languages
English (en)
Original Assignee
Vernalis R&D Ltd
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis R&D Ltd, Servier Lab filed Critical Vernalis R&D Ltd
Publication of PT3468974T publication Critical patent/PT3468974T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT177279270T 2016-06-10 2017-06-09 Novos derivados de piperidinilo, um processo para a sua preparação e composições farmacêuticas que os contêm PT3468974T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1655392A FR3052452B1 (fr) 2016-06-10 2016-06-10 Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PT3468974T true PT3468974T (pt) 2020-03-25

Family

ID=56943687

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177279270T PT3468974T (pt) 2016-06-10 2017-06-09 Novos derivados de piperidinilo, um processo para a sua preparação e composições farmacêuticas que os contêm

Country Status (45)

Country Link
US (1) US11046681B2 (pt)
EP (1) EP3468974B1 (pt)
JP (1) JP6928005B2 (pt)
KR (1) KR20190016106A (pt)
CN (1) CN109311888B (pt)
AR (1) AR108706A1 (pt)
AU (1) AU2017277734B2 (pt)
BR (1) BR112018075433A2 (pt)
CA (1) CA3027014C (pt)
CL (1) CL2018003474A1 (pt)
CO (1) CO2018013210A2 (pt)
CR (1) CR20180564A (pt)
CU (1) CU20180145A7 (pt)
CY (1) CY1122870T1 (pt)
DK (1) DK3468974T3 (pt)
DO (1) DOP2018000270A (pt)
EA (1) EA037211B1 (pt)
EC (1) ECSP18090144A (pt)
ES (1) ES2775789T3 (pt)
FR (1) FR3052452B1 (pt)
GE (1) GEP20207160B (pt)
HR (1) HRP20200361T1 (pt)
HU (1) HUE049507T2 (pt)
IL (1) IL263463B (pt)
LT (1) LT3468974T (pt)
MA (1) MA45222B1 (pt)
MD (1) MD3468974T2 (pt)
ME (1) ME03670B (pt)
MX (1) MX2018015216A (pt)
MY (1) MY196562A (pt)
NI (1) NI201800132A (pt)
PE (1) PE20220567A1 (pt)
PH (1) PH12018502515A1 (pt)
PL (1) PL3468974T3 (pt)
PT (1) PT3468974T (pt)
RS (1) RS60029B1 (pt)
RU (1) RU2743163C2 (pt)
SG (1) SG11201810629QA (pt)
SI (1) SI3468974T1 (pt)
SV (1) SV2018005791A (pt)
TN (1) TN2018000410A1 (pt)
TW (1) TWI620750B (pt)
UA (1) UA123794C2 (pt)
UY (1) UY37288A (pt)
WO (1) WO2017212012A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3017020C (en) 2016-03-07 2024-01-16 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
WO2018195450A1 (en) 2017-04-21 2018-10-25 Epizyme, Inc. Combination therapies with ehmt2 inhibitors
UY37861A (es) 2017-08-28 2019-03-29 Enanta Pharm Inc Agentes antivirales contra la hepatitis b
EP3717482A1 (en) * 2017-11-29 2020-10-07 Les Laboratoires Servier SAS New piperidinyl derivatives as inhibitors of ubiquitin specific protease 7
GB201801562D0 (en) * 2018-01-31 2018-03-14 Almac Diagnostics Ltd Pharmaceutical compounds
UY38291A (es) * 2018-07-05 2020-06-30 Servier Lab Nuevos derivados de amino-pirimidonilo un proceso para su preparación y composiciones farmacéuticas
BR112021005091A2 (pt) 2018-09-21 2021-06-08 Enanta Pharmaceuticals, Inc. heterociclos funcionalizados como agentes antivirais
UY38423A (es) * 2018-10-19 2021-02-26 Servier Lab Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
EP3883570A4 (en) 2018-11-21 2022-07-13 Enanta Pharmaceuticals, Inc. FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS
CN113365696A (zh) * 2018-12-06 2021-09-07 阿尔麦克探索有限公司 药物化合物和其作为泛素特异性蛋白酶19(usp19)抑制剂的用途
WO2020247444A1 (en) 2019-06-03 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
US11472808B2 (en) 2019-06-04 2022-10-18 Enanta Pharmaceuticals, Inc. Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
WO2020247561A1 (en) 2019-06-04 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
WO2021007488A1 (en) 2019-07-11 2021-01-14 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
US11236108B2 (en) 2019-09-17 2022-02-01 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
CN113087718B (zh) * 2020-01-09 2024-02-09 四川科伦博泰生物医药股份有限公司 噻吩并嘧啶酮类化合物及其医药应用
CN112608320B (zh) * 2020-01-16 2023-03-17 中国药科大学 哌啶类化合物及其制备方法和医药用途
GB202001980D0 (en) 2020-02-13 2020-04-01 Almac Discovery Ltd Therapeutic mentods
WO2021188414A1 (en) 2020-03-16 2021-09-23 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20071162A1 (es) * 2005-12-21 2007-11-30 Schering Corp Combinacion de un antagonista/agonista inverso de h3 y un supresor del apetito
CA2679807A1 (en) * 2007-03-02 2008-09-12 Schering Corporation Piperidine derivatives and methods of use thereof
EP2565186A1 (en) * 2011-09-02 2013-03-06 Hybrigenics S.A. Selective and reversible inhibitors of ubiquitin specific protease 7
TWI770525B (zh) * 2014-12-30 2022-07-11 美商瓦洛健康公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
DK3468971T3 (da) * 2016-06-10 2020-05-18 Servier Lab Nye (hetero)aryl-substituterede piperidinyl-derivativer, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende dem

Also Published As

Publication number Publication date
RU2743163C2 (ru) 2021-02-15
DOP2018000270A (es) 2019-05-15
MX2018015216A (es) 2019-04-25
IL263463A (en) 2019-01-31
PH12018502515B1 (en) 2019-09-30
RS60029B1 (sr) 2020-04-30
DK3468974T3 (da) 2020-05-11
AU2017277734B2 (en) 2021-07-01
CY1122870T1 (el) 2021-05-05
JP6928005B2 (ja) 2021-09-01
BR112018075433A2 (pt) 2019-03-19
EA037211B1 (ru) 2021-02-19
EP3468974A1 (en) 2019-04-17
MD3468974T2 (ro) 2020-05-31
ECSP18090144A (es) 2019-01-31
MA45222B1 (fr) 2020-04-30
US20190144448A1 (en) 2019-05-16
RU2018147430A (ru) 2020-07-10
GEP20207160B (en) 2020-10-12
FR3052452A1 (pt) 2017-12-15
MA45222A (fr) 2019-04-17
WO2017212012A1 (en) 2017-12-14
CL2018003474A1 (es) 2019-05-24
CR20180564A (es) 2019-03-04
KR20190016106A (ko) 2019-02-15
FR3052452B1 (fr) 2018-06-22
TW201802092A (zh) 2018-01-16
AR108706A1 (es) 2018-09-19
PH12018502515A1 (en) 2019-09-30
SV2018005791A (es) 2019-01-16
ES2775789T3 (es) 2020-07-28
UY37288A (es) 2018-01-02
SI3468974T1 (sl) 2020-07-31
TWI620750B (zh) 2018-04-11
CU20180145A7 (es) 2019-07-04
RU2018147430A3 (pt) 2020-07-10
IL263463B (en) 2021-01-31
SG11201810629QA (en) 2018-12-28
CN109311888B (zh) 2021-09-14
JP2019517556A (ja) 2019-06-24
ME03670B (en) 2020-10-20
HRP20200361T1 (hr) 2020-06-12
TN2018000410A1 (en) 2020-06-15
US11046681B2 (en) 2021-06-29
PL3468974T3 (pl) 2020-07-13
CO2018013210A2 (es) 2018-12-28
HUE049507T2 (hu) 2020-09-28
CA3027014C (en) 2021-01-05
CN109311888A (zh) 2019-02-05
NI201800132A (es) 2019-04-08
EA201892838A1 (ru) 2019-06-28
EP3468974B1 (en) 2020-02-12
CA3027014A1 (en) 2017-12-14
PE20220567A1 (es) 2022-04-13
MY196562A (en) 2023-04-19
UA123794C2 (uk) 2021-06-02
LT3468974T (lt) 2020-04-10
AU2017277734A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
IL263463B (en) New piperidinyl compounds, a process for their preparation and pharmaceutical preparations containing them
HK1254656A1 (zh) 新的二環衍生物、其製備方法以及含有它們的藥物組合物
HK1254657A1 (zh) 新的羥基酯衍生物、其製備方法以及含有它們的藥物組合物
HK1254477A1 (zh) 新的羥基酸衍生物、其製備方法以及含有它們的藥物組合物
HRP20181806T1 (hr) Novi aminokiselinski derivati, postupak za njihovu pripravu te farmaceutski pripravci koji ih sadrže
ZA201804770B (en) New ammonium derivatives, a process for their preparation and pharmaceutical compositions containing them